Journal of Clinical Pathology 2007;60:307-310
ORIGINAL ARTICLE
Expression of peroxisome proliferator activated receptor
and cyclo-oxygenase 2 in primary and recurrent ovarian carcinoma
1 Institute of Pathology, University Hospital Basel, Basel, Switzerland
2 Department of Gynecology and Obstetrics, University Hospital Basel, Basel, Switzerland
3 Institute of Pathology, University of Regensburg, Regensburg, Germany
Correspondence to:
Correspondence to:
PD Dr G Singer
Institute of Pathology, University Hospital Basel, Schönbeinstrasse 40, CH-4031 Basel, Switzerland; gsinger{at}uhbs.ch
Aim: Peroxisome proliferator-activated receptor
(PPAR
) has emerged as a potential therapeutic target in several types of cancer. In ovarian carcinomas, limited and conflicting data on PPAR
protein expression have been reported.
Methods: The immunoexpression of PPAR
and its putative target cyclo-oxygenase 2 (COX2) was investigated in tumour tissues from 80 patients with primary and corresponding recurrent ovarian serous carcinomas after conventional platinum-based chemotherapy.
Results: PPAR
expression was observed in 29% of primary and recurrent carcinomas. In the recurrent tumours, PPAR
expression inversely correlated with COX2 overexpression in both chemosensitive (p = 0.02) and chemoresistant (p = 0.04) carcinomas.
Conclusions: The data indicate that PPAR
may represent a potential target for second-line treatment in ovarian cancers.
Abbreviations: COX2, cyclo-oxygenase 2; IHC, immunohistochemistry; PPAR
, peroxisome proliferator-activated receptor
; TMA, tissue microarray
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
